Last edition
News about "XCOPRI clinical trial results"
Ono Pharmaceuticals Gets Nod for XCOPRI Tablets in Japan
Ono has received manufacturing and marketing approval in Japan for XCOPRI tablets to treat partial-onset seizures, with or without secondary generalisation.
XCOPRI Clinical Trial Results | 18/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members